NASDAQ · Stocky rates: Avoid

HSHP

$15.47 ▼ -0.96% as of 5 Aug, 20:00
30
/ 100
Avoid

What Stocky thinks

Avoid. HSHP's 31.8 Growth Compounder Score reflects anemic revenue expansion, while a 27.5 Leadership Alignment score signals misaligned incentives—likely dilutive equity grants or founder-CEO separation without skin-in-the-game. Though trading at a modest 12.3× forward P/E, the Vulnerable profile suggests structural competitive pressures or margin erosion that offset valuation appeal. Better risk-reward elsewhere.

Compounder Score
42/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
28/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
0/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
42/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for HSHP:

30
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 30/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

28
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

0
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

HSHP (HSHP) — frequently asked

Is HSHP (HSHP) a good investment right now?

Stocky rates HSHP (HSHP) at 30/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. HSHP's 31.8 Growth Compounder Score reflects anemic revenue expansion, while a 27.5 Leadership Alignment score signals misaligned incentives—likely dilutive equity grants or founder-CEO separation without skin-in-the-game. Though

What is HSHP's Stocky Verdict?

HSHP's current Stocky Verdict is 30/100, placing it in the "Avoid" band. This composite combines a 42/100 Compounder score, 28/100 Leadership, Moat rating, and analyst signal.

Does HSHP have a competitive moat?

Stocky hasn't finalised a Moat Score for HSHP yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is HSHP's leadership aligned with shareholders?

HSHP scores 28/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to HSHP?

HSHP's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to HSHP.

This is just the surface. See the whole picture on HSHP.

Sign up free and unlock the full analysis on HSHP — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering HSHP — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for HSHP.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how HSHP changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to HSHP?" · "Is HSHP overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
30
/ 100 · Avoid

Or jump straight to the interactive dashboard for HSHP in the app.